Next-Generation Bioresponsive Wound Healing System

Publication ID: 24-11857693_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Bioresponsive Wound Healing System,” Published Technical Disclosure No. 24-11857693_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857693_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,693.

Summary of the Inventive Concept

A futuristic wound healing system that integrates advanced technologies such as programmable matrices, AI-assisted diagnostics, electrical stimulation, quantum dot delivery, and 3D-printed scaffolds to revolutionize wound care.

Background and Problem Solved

The original medical sealant glue capable of promoting wound healing has limitations in adapting to dynamic wound conditions, personalizing treatment, and leveraging cutting-edge technologies. The next-generation bioresponsive wound healing system addresses these limitations by incorporating self-healing polymers, bioactive molecules, AI-assisted diagnostics, electrical stimulation, quantum dot delivery, and 3D-printed scaffolds to provide a more effective and personalized wound healing solution.

Detailed Description of the Inventive Concept

The next-generation bioresponsive wound healing system consists of a programmable matrix that adapts to dynamic wound conditions, an AI-assisted diagnostic platform that integrates real-time wound monitoring data with machine learning algorithms to predict optimal treatment strategies, a wearable electrical stimulation device powered by a bio-harvested energy source, a nanoscale wound healing agent leveraging quantum dot technology, and a 3D-printed, implantable wound healing scaffold incorporating living cells and growth factors. These components work in tandem to stimulate tissue regeneration, enhance treatment efficacy, and reduce side effects.

Novelty and Inventive Step

The novelty of the next-generation bioresponsive wound healing system lies in its integration of advanced technologies, such as programmable matrices, AI-assisted diagnostics, electrical stimulation, quantum dot delivery, and 3D-printed scaffolds, to provide a more effective and personalized wound healing solution. The inventive step resides in the synergistic combination of these technologies to create a bioresponsive system that adapts to dynamic wound conditions and optimizes treatment outcomes.

Alternative Embodiments and Variations

Alternative embodiments of the next-generation bioresponsive wound healing system could include the use of different types of programmable matrices, AI-assisted diagnostic platforms, electrical stimulation devices, nanoscale wound healing agents, and 3D-printed scaffolds. Variations could also include the integration of additional technologies, such as gene editing or stem cell therapy, to further enhance treatment efficacy and personalize wound care.

Potential Commercial Applications and Market

The next-generation bioresponsive wound healing system has significant commercial potential in the wound care market, which is projected to grow significantly in the coming years. The system's ability to provide personalized, effective, and efficient wound healing solutions could revolutionize the industry and address the growing need for advanced wound care technologies.

CPC Classifications

SectionClassGroup
A A61 A61L24/043
A A61 A61K35/28
A A61 A61L24/0005

Field of Art

Biomedical engineering focused on wound healing technologies, specifically medical sealants, tissue regeneration, and advanced drug delivery systems. Requires expertise in polymer chemistry, biomaterials, cellular biology, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or materials scientist with advanced degree, working knowledge of biomaterials, wound healing technologies, drug delivery mechanisms, and experience in developing medical sealants and regenerative technologies

Obviousness Rationale

A PHOSITA would recognize that the PTD's advanced wound healing system represents predictable technological extensions of the source patent's foundational medical sealant approach. The disclosed variations leverage known biomedical engineering techniques to enhance wound healing mechanisms through incremental technological improvements. The integration of AI, electrical stimulation, and nanoscale delivery represents logical progressions in wound healing technology that build upon established principles of tissue regeneration and targeted molecular interventions.

Obvious Combinations & Variations

Source Patent Element
Medical sealant glue with crosslinked compounds and functional groups
PTD Variation
Programmable matrix using self-healing polymers and bioactive molecules
Obviousness Reasoning
Predictable evolution of medical sealant technology using known polymer engineering techniques to create adaptive wound healing matrices with enhanced responsiveness
Source Patent Element
Exosome-based healing components from mesenchymal stem cells
PTD Variation
3D-printed scaffold incorporating living cells and growth factors
Obviousness Reasoning
Natural progression of stem cell and regenerative medicine techniques, representing a straightforward application of known tissue engineering principles
Source Patent Element
Crosslinked compounds with nucleophilic and electrophilic functional groups
PTD Variation
Quantum dot technology for targeted therapeutic payload delivery
Obviousness Reasoning
Logical extension of molecular targeting strategies using established nanoscale drug delivery techniques familiar to biomedical engineers
Source Patent Element
Chitosan-based medical sealant components
PTD Variation
AI-assisted diagnostic platform for personalized wound treatment
Obviousness Reasoning
Predictable integration of machine learning and diagnostic technologies with existing wound healing methodologies, representing an obvious technological convergence
Source Patent Element
Active polyethylene glycol crosslinking agents
PTD Variation
Electrical stimulation device for tissue repair with bio-harvested energy
Obviousness Reasoning
Foreseeable application of known bioelectrical stimulation techniques to enhance wound healing processes, using standard engineering design approaches
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857693 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations of the next-generation wound healing system to be obvious and lacking inventive step. The disclosed technological combinations represent predictable extensions of existing medical sealant and tissue regeneration technologies, utilizing standard biomedical engineering techniques to incrementally improve wound healing interventions.

Original Patent Information

Patent NumberUS 11,857,693
TitleMedical sealant glue capable of promoting wound healing and preparation method thereof
Assignee(s)Shandong Branden Medical Device Co.,Ltd